Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: Clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes

Journal of Clinical Microbiology

Volumn 37, Issue 12, 1999, Pages 4020-4027

  Siu, L K ^a   Lu, Po Liang ^a   Hsueh, Po Ren ^a   Lin, F M ^a   Chang, Shan Chwen ^a   Luh, Kwen Tay ^a   Ho, Monto ^a   Lee, Chin Yun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; AZTREONAM; BETA LACTAMASE INHIBITOR; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFMETAZOLE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; MEROPENEM; PIPERACILLIN; TAZOBACTAM;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; CHILD; CLINICAL ARTICLE; ESCHERICHIA COLI; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; KLEBSIELLA PNEUMONIAE; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; PRIORITY JOURNAL;

ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA;

EID: 0032701986     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.12.4020-4027.1999     Document Type: Article

References (43)

1. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Morre, J. G. Seidman, and J. A. Smith. 1995. Miniprep of bacterial genomic DNA. In Current protocols in molecular biology, unit 2.4.2. Massachusetts General Hospital and Harvard Medical School, Boston, Mass.
2. Billot-Klein, D., L. Gutmann, and E. Collatz. 1990. Nucleotide sequence of the SHV-5 β-lactamase gene of a Klebsiella pneumoniae plasmid. Antimicrob. Agents Chemother. 34:2439-2441.
3. Brun-Buisson, C., P. Legrand, A. Philippon, F. Montravers, M. Ansquer, and J. Duval. 1987. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet ii:302-306.
4. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
5. Chen, M. L., Y. C. Chen, H. J. Pan, S. C. Chang, L. S. Yang, S. W. Ho, K. T. Luh, W. C. Hsieh, and C. Y. Chuang. 1995. Secular trends in the etiology of nosocomial infection at a teaching hospital in Taiwan, 1981-1994. Chin. J. Microbiol. Immunol. 28:203-217.
6. Chong, C. Y., A. M. Tan, and J. Lou. 1998. Infections in acute lymphoblastic leukaemia. Ann. Acad. Med. Singapore. 27:491-495.
7. Cordonnier, C., R. Herbrecht, J. L. Pico, M. Gardembas, A. Delmer, M. Delain, P. Moreau, S. Ladeb, V. Nalet, C. Rollin, and J. J. Gres. 1997. Cefepine/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. Clin. Infect. Dis. 24:41-51.
8. Cukler, L., P. Lutzler, A. Bizien, and J. L. Avril. 1999. Investigation of an epidemic of an extended spectrum beta-lactamase producing Escherichia coli in a geriatrics department. Pathol. Biol. 47:440-444.
9. Du Bois, S. K., M. S. Marriott, and S. G. B. Amyes. 1995. TEM- and SHV-derived extended-spectrum β-lactamases: relationship between selection, structure and function. J. Antimicrob. Chemother. 35:7-22.
10. Gniadkowski, M., A. Palucha. P. Grzesiowski, and W. Hryniewicz. 1998. Outbreak of ceftazidime-resistant Klebsiella pneumoniae in a pediatric hospital in Warsaw, Poland: clonal spread of the TEM-47 extended-spectrum beta-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-5-like ESBL-encoding gene. Antimicrob. Agents Chemother. 42: 3079-3085.
11. Goussard, S., and P. Courvalin. 1991. Sequence of the genes blaT-1B and blaT-2. Gene 15:71-73.
12. Green, M., and K. Barbadora. 1998. Recovery of ceftazidime-resistant Klebsiella pneumoniae from pediatric liver and intestinal transplant recipients. Pediatr. Transplant. 2:224-230.
13. Grogan, J., H. Murphy, and K. Butler. 1998. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Dublin paediatric hospital. Bi. J. Biomed. Sci. 55:111-117.
14. Gunseren, F., L. Mamikoglu, S. Ozturk, M. Yucesoy, K. Biberoglu, N. Yulug, M. Doganay, B. Sumerkan, S. Kocagoz, S. Unal, S. Cetin, S. Calangu, I. Koksal, H. Leblebicioglu, and M. Gunaydin. 1999. A surveillance study of antimicrobial resistance of gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey. J. Antimicrob. Chemother. 43:373-378.
15. Heritage, J., P. M. Hawkey, N. Todd, and I. J. Lewis. 1992. Transposition of the gene encoding a TEM-12 extended-spectrum beta-lactamase. Antimicrob. Agents Chemother. 36:1981-1986.
16. Hibbert-Rogers, L. C., J. Heritage, D. M. Gascoyne-Binzi, P. M. Hawkey, N. Todd, I. J. Lewis, and C. Bailey. 1995. Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward. J. Antimicrob. Chemother. 36:65-82.
17. Hughes, W. T., D. Armstrong, G. P. Bodey, A. E. Brown, J. E. Edwards, R. Feld, P. Pizzo, K. V. Rolston, J. L. Shenep, and L. S. Young. 1997. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin. Infect. Dis. 25:551-573.
18. Jan, I. S., P. R. Hsueh, T. J. Teng, S. W. Ho, and K. T. Luh. 1998. Antimicrobial susceptibility testing for Klebsiella pneumoniae isolates resistant to extended spectrum beta-lactam antibiotics. J. Formos. Med. Assoc. 97:661-666.
19. Jarlier, V., M. H. Nicolas, G. Fournier, and A. Philippon. 1998. Extended broad-spectrum β-lactamases conferring resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
20. Kado, C. I., and S. T. Liu. 1981. Rapid procedure for detection and isolation of large and small plasmids. J. Bacteriol. 145:1365-1373.
21. Karas, J. A., D. G. Pillay, D. Muckart, and A. W. Sturm. 1996. Treatment failure due to extended spectrum beta-lactamase. J. Antimicrob. Chemother. 37:203-204.
22. Liu, P. Y., J. C. Tung, S. C. Ke, and S. L. Chen. 1998. Molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates in a district hospital in Taiwan. J. Clin. Microbiol. 36:2759-2762.
23. Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
24. Lu, P. L., P. R. Hsueh, C. C. Hung, S. C. Chang, and K. T. Luh. 1998. Clinical feature of extended spectrum beta-lactam antibiotics resistant Escherichia coli bacteremia, p. 47. In Abstracts of the 1998 Annual Meeting of the Infectious Disease Society of Republic of China.
25. Lucet, J. C., S. Chevret, D. Decre, D. Vanjak, A. Macrez, J. P. Bedos, M. Wolf, and B. Regnier. 1996. Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin. Infect. Dis. 22:430-436.
26. Mabilat, C., and S. Goussard. 1993. PCR detection and identification of genes for extended-spectrum β-lactamases, p. 553-563. In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C.
27. Maschmeyer, G., W. Hiddemann, H. Link, O. A. Cornely, D. Buchheidt, B. Glass, and D. Adam. 1997. Management of infections during intensive treatment of hematologic malignancies. Ann. Hematol. 75:9-16.
28. Matthew, M., and A. M. Harris. 1976. Identification of beta-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy. J. Gen. Microbiol. 94:55-67.
29. Mercier, J., and R. C. Levesque. 1990. Cloning of SHV-2, OHIO-1, and OXA-6 beta-lactamases and cloning and sequencing of SHV-1 beta-lactamase. Antimicrob. Agents Chemother. 34:1577-1583.
30. National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A6. National Committee for Clinical Laboratory Standards. Wayne, Pa.
31. National Committee for Clinical Laboratory Standards. 1997. Performance standards for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
32. National Committee for Clinical Laboratory Standards. 1999. Performance standards for antimicrobial susceptibility testing: ninth information supplement, (M100-S9) vol. 19, no. 36. M2-A6 and M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
33. Naumovski, L., J. P. Quinn, D. Miyashiro, M. Patel, K. Bush, S. B. Singer, D. Graves, T. Palzkill, and A. M. Arvin. 1992. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamase in isolates from cancer patients. Antimicrob. Agents Chemother. 36:1991-1996.
34. Nordmann, P. 1998. Trends in beta-lactam resistance among Enterobacteriaceae. Clin. Infect. Dis. 27(Suppl. 1):S100-S106.
35. Paterson, D. L., W. Ko, A. V. Gottberg, S. Mohapatra, J. M. Casellas, L. Mulazimoglu, H. Goossens, F. Trenholme, K. Klugman, L. B. Rice, R. A. Bonomo, and V. L. Yu. 1998. In vitro susceptibility and clinical outcome of bacteremia due to extended spectrum beta-lactamase (ESBL) producing K. pneumoniae, abstr. 188. In Abstracts of the 36th Annual Meeting of the Infectious Diseases Society of America.
36. Philippon, A., G. Arlet, and P. H. Lagrange. 1994. Origin and impact of plasmid-mediated extended-spectrum beta-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 13:S17-S29.
37. Rasheed, J. K., C. Jay, B. Metchock, F. Berkowitz, L. Weigel, J. Crellin, C. Steward, B. Hill, A. A. Medeiros, and F. C. Tenover. 1997. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob. Agents Chemother. 41:647-653.
38. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
39. Schiappa, D. A., M. K. Hayden, M. G. Matushek, F. N. Hashemi, J. Sullivan, K. Y. Smith, D. Miyashiro, J. P. Quinn, R. A. Weinstein, and G. M. Trenholme. 1996. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J. Infect. Dis. 174:529-536.
40. Schimpff, S. C. 1986. Empiric antibiotic therapy for granulocytopenic cancer patients. Am. J. Med. 80:13-20.
41. Schoonmaker, D., T. Heimberger, and G. Birkhead. 1992. Comparison of ribotyping and restriction enzyme analysis using pulsed-field gel electrophoresis for distinguishing Legionella pneumophila isolates obtained during a nosocomial outbreak. J. Clin. Microbiol. 30:1491-1498.
42. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
43. Wiener, J., J. P. Quinn, P. A. Bradford, R. V. Goering, C. Nathan, K. Bush, and R. A. Weinstein. 1999. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281:517-523.